Design, synthesis and evaluation of 6-aryl-indenoisoquinolone derivatives dual targeting ERα and VEGFR-2 as anti-breast cancer agents
作者:Zhichao Tang、Chengzhe Wu、Tianlin Wang、Kejing Lao、Yejun Wang、Linyi Liu、Moses Muyaba、Pei Xu、Conghui He、Guoshun Luo、Zhouyang Qian、Shaoxiong Niu、Lijun Wang、Ying Wang、Hong Xiao、Qidong You、Hua Xiang
DOI:10.1016/j.ejmech.2016.04.029
日期:2016.8
The estrogen receptors have played important roles in breast cancer development and progression. Selective estrogen receptor modulators, such as Tamoxifen, have showed great benefits in the treatment and prevention of breast cancer. But the disadvantages of induction of endometrial cancer and drug resistance have limited their use. Multiple ligand which act at multiple biomolecular targets may exert
雌激素受体在乳腺癌的发生和发展中起着重要的作用。选择性雌激素受体调节剂,如他莫昔芬,在乳腺癌的治疗和预防中显示出巨大的益处。但是诱导子宫内膜癌和耐药性的缺点限制了它们的使用。作用于多个生物分子靶标的多个配体可以发挥有益的优点,即具有提高的功效和较低的副作用发生率。在这项工作中,我们描述了一系列的6-芳基-茚基异喹诺酮衍生物作为ERα和VEGFR-2双重抑制剂的合成和评估。这些化合物具有良好的ERα结合亲和力和ERα拮抗活性,以及强大的VEGFR-2抑制能力。他们还具有出色的抗MCF-7,MDA-MB-231,石川和HUVEC细胞系。选择性化合物的进一步研究21c显示它能够抑制MCF-7细胞中VEGFR-2的激活和Raf-1 / MAPK / ERK途径的信号转导。